골밀도측정기 시장 : 유형별, 용도별, 기술별, 최종사용자별, 지역별, 기회 및 예측(2017-2031년)

Global bone densitometers market is projected to witness a CAGR of 3.9% during the forecast period 2024-2031F, growing from USD 331.2 million in 2023 to USD 449.8 million in 2031F. Various factors shape the global bone densitometers market, including the increasing prevalence of osteoarthritis and vitamin deficiencies, technological advancements, implementation of training programs, growing use in patients with osteopenia, increasing demand for dual-energy x-ray absorptiometry, and rising use of detection of sports injuries.

The increasing prevalence of osteoarthritis and vitamin deficiencies compel the need for proper detection and monitoring, ultimately leading to a greater demand for bone densitometer systems fueling the growth of global bone densitometers market. Advancements in technologies further play a critical role in the expansion of the market. Technologies such as artificial intelligence enhance the efficiency of densitometers and improve the accuracy of the outcomes obtained by aiding healthcare professionals in making more informed decisions. To operate these advanced densitometer equipment, major companies in the market are focusing on training their manpower with the necessary skills required to operate the equipment.

The global bone densitometers market environment is affected by the growing use of densitometers in diagnosing osteopenia. The early detection of the disease can help prevent progression to a more severe form of the disease called osteoporosis in which the bone becomes brittle and fragile. Increasing demand for dual-energy x-ray absorptiometry (DXA) is observed in the global bone densitometers market. DXA is a method of choice in assessing bone density because of its potential to speculate accurate results. Athletes can more effectively control their health since bone densitometers can reliably predict bone abnormalities. The market for bone densitometers is expanding globally, which is partly due to the rise in sports-related injuries.

For instance, Fujifilm India, a Japan-based multinational conglomerate, introduced FDX Visionary-DR, a bone density detector that supports various body composition analysis and bone densitometry solutions at the 75th National Conference of Indian Radiological and Imaging Association (IRIA) held in February 2023.

Technological Advancements

Technological advancements, such as AI, are driving the growth of global bone densitometers market. AI developers struggle to create an algorithm for the detection and management of bone deformities. A deep learning model can be used to help patients who are susceptible to osteoporosis. These AI-based algorithms can very well predict the deformities and the results are comparable to that of the physician and sometimes to the superiors. Manual measurement of bone mineral density is prone to human errors and is a time-consuming process leading to low patient output further accelerating the demand for the use of advanced technologies.

For instance, Bupa Hong Kong, a UK-based healthcare company, announced the establishment of Alpha Medical Diagnostic Centre in partnership with its healthcare provider arm, Quality HealthCare Medical Services Limited (QHMS), in November 2023. This new diagnostic center is in Pioneer Centre in Mong Kok and provides services such as ultrasonography, bone densitometry, and digital X-rays.

Implementation of Training Programs

Major companies in global bone densitometers market are implementing training programs to train the people operating the densitometer equipment so that they become competent in utilizing the innovative functions and features that contemporary densitometers provide. The operation of the equipment and the evaluation of diagnostic images are a part of the training. These programs are specifically designed to address the growing requirement for skilled personnel in diagnostic imaging. Adequate training improves assessments' precision and lowers the chances of operator error resulting in improved patient outcomes in bone health management.

For instance, ImagingWorks, a career training program for diagnostic imaging was introduced by RadNet, Inc., an American radiology company in February 2024. The program was created in partnership with JVS SoCal, a not-for-profit organization that offers top-notch programs to agencies and businesses.

Growing Use in Patients with Osteopenia

An unhealthy lifestyle and excessive consumption of certain medications result in an increased number of cases of Osteopenia, a clinical condition in which bone mineral density (BMD) drops to below acceptable normal value, which is one of the major driving factors for the growth in the global bone densitometers market. To prevent osteoporosis, a more severe form of the disease, timely detection of osteopenia becomes essential. Through densitometers, early detection is possible enabling quick intervention. With increased awareness regarding the issue, a steep rise in screening rates is observed leading to more demand for densitometer equipment.

For instance, in November 2023, Medimaps Group, a Swiss med-tech company launched Trabecular Bone Score (TBS iNsight), a surrogate of bone microarchitecture boosted by AI on a diagnostic platform from OsteoSys Co., a leading Bone Mineral Densitometer brand. TBS allows accurate diagnosis of osteopenia and osteoporosis.

Increasing Demand for Dual-Energy X-Ray Absorptiometry

The global bone densitometers market has increased demand for dual-energy x-ray absorptiometry (DXA). DXA is a quick, simple, and non-invasive procedure that offers a lot of benefits including lower radiation exposure, more precise measurements, faster data collection and stability of the energy source. DXA is considered a gold standard for detecting fracture risk and diagnosing osteoporosis. It is highly effective in examining hip and spine as it provides highly accurate images of the structure and constitution of bones. Increased occurrence of osteoporosis and the need for quick diagnosis make it a most sought-after technique.

For instance, when it comes to evaluating low bone mineral density (BMD), Cambridge Memorial Hospital (CMH) was the first hospital in Ontario to adopt artificial intelligence (AI) screening technology for clinical use in November 2023. The technology works in the background of routine DXA X-ray examinations.

Growing European Market

The global bone densitometers market in Europe is growing two-fold because of various supporting factors such as the region's focus on research and development that leads to the development of technologically advanced densitometry equipment. These technologies are required to meet the increasing demand of Europe's demographic which mostly includes the geriatric population who often suffers from bone disorders such as osteoporosis and fractures which provides a huge scope for the bone diagnosis industry. There is a high demand for diagnostic tests because of the increasing awareness of bone disorders and screening methods.

For instance, in September 2022, ProAxsis, a diagnostic tool for bone fragility, collectively developed by the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE) received approval for sale in Switzerland and the European Economic Area. The device was developed with the intent to complement bone densitometers.

Future Market Scenario (2024 - 2031F)

Global bone densitometers market will be driven by the amalgamation of electronic health records (EHRs) with bone densitometry technology in the future.

Increased focus on preventive healthcare will increase the demand for the bone densitometers industry, affecting the growth of global bone densitometers market.

Emerging global trends of personalized medicine can create the desired opportunities for the global bone densitometers market.

The rising acceptance of remote monitoring solutions can create opportunities for remote delivery of bone health services bolstering the growth of global bone densitometers market.

Key Players Landscape and Outlook

Major companies in global bone densitometers market are opting for collaborations to grow in the marketplace. Companies with similar interests align with each other to foster the market by combining their knowledge, resources, and technologies. Through these collaborations research and development activities get a boost which helps companies develop innovative solutions for increasing reach and market penetration by integrating distribution and marketing resources. Companies can fulfill several markets demands to grasp the rising demand for diagnosis of bone health equipment and strengthen their hold in the market.

For instance, in October 2023, GE HealthCare and University Hospitals Cleveland Medical Center entered a 10-year strategic partnership to upgrade imaging and execute digital solutions that could improve patient outcomes and streamline processes. GE is the sole provider of bone densitometers and hundreds of other types of equipment, as a part of the agreement.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Bone Densitometers Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
  • 4.1.2.By Volume
• 4.2.By Type
  • 4.2.1.Central Scan
  • 4.2.2.Peripheral Scan
• 4.3.By Application
  • 4.3.1.Cystic Fibrosis
  • 4.3.2.Chronic Kidney Disease
  • 4.3.3.Osteopenia & Osteoporosis
  • 4.3.4.Body Composition Measurement
  • 4.3.5.Rheumatoid Arthritis
• 4.4.By Technology
  • 4.4.1.Single X-ray Absorptiometry
  • 4.4.2.Dual Energy X-ray Absorptiometry
  • 4.4.3.Quantitative Computed Tomography
  • 4.4.4.Others
• 4.5.By End-user
  • 4.5.1.Hospitals & Clinics
  • 4.5.2.Diagnostic Centers
  • 4.5.3.Academic and Research Institutes
  • 4.5.4.Others
• 4.6.By Region
  • 4.6.1.North America
  • 4.6.2.Europe
  • 4.6.3.Asia-Pacific
  • 4.6.4.South America
  • 4.6.5.Middle East and Africa
• 4.7.By Company Market Share (%), 2023

5.Global Bone Densitometers Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
    • 5.1.1.2.By Volume
  • 5.1.2.By Type
    • 5.1.2.1.Central Scan
    • 5.1.2.2.Peripheral Scan
  • 5.1.3.By Application
    • 5.1.3.1.Cystic Fibrosis
    • 5.1.3.2.Chronic Kidney Disease
    • 5.1.3.3.Osteopenia & Osteoporosis
    • 5.1.3.4.Body Composition Measurement
    • 5.1.3.5.Rheumatoid Arthritis
  • 5.1.4.By Technology
    • 5.1.4.1.Single X-ray Absorptiometry
    • 5.1.4.2.Dual Energy X-ray Absorptiometry
    • 5.1.4.3.Quantitative Computed Tomography
    • 5.1.4.4.Others
  • 5.1.5.By End-user
    • 5.1.5.1.Hospitals & Clinics
    • 5.1.5.2.Diagnostic Centers
    • 5.1.5.3.Academic and Research Institutes
    • 5.1.5.4.Others
  • 5.1.6.United States*
    • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
    • 5.1.6.2.By Type
      • 5.1.6.2.1.Central Scan
      • 5.1.6.2.2.Peripheral Scan
    • 5.1.6.3.By Application
      • 5.1.6.3.1.Cystic Fibrosis
      • 5.1.6.3.2.Chronic Kidney Disease
      • 5.1.6.3.3.Osteopenia & Osteoporosis
      • 5.1.6.3.4.Body Composition Measurement
      • 5.1.6.3.5.Rheumatoid Arthritis
    • 5.1.6.4.By Technology
      • 5.1.6.4.1.Single X-ray Absorptiometry
      • 5.1.6.4.2.Dual Energy X-ray Absorptiometry
      • 5.1.6.4.3.Quantitative Computed Tomography
      • 5.1.6.4.4.Others
    • 5.1.6.5.By End-user
      • 5.1.6.5.1.Hospitals & Clinics
      • 5.1.6.5.2.Diagnostic Centers
      • 5.1.6.5.3.Academic and Research Institutes
      • 5.1.6.5.4.Others
  • 5.1.7.Canada
  • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East & Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Type
• 6.2.By Application
• 6.3.By Technology
• 6.4.By End-user
• 6.5.By Region

7.Macro Environment and Industry Structure

• 7.1.Demand Supply Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat from New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Patent Landscape
• 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)
• 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.GE Healthcare
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products & Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus & Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Diagnostic Medical System SA
• 13.3.Hitachi Ltd
• 13.4.Medonica Co. Ltd.
• 13.5.Hologic, Inc.
• 13.6.BeamMed Ltd.
• 13.7.Lone Oak Medical Technologies LLC
• 13.8.Swissray International Inc.
• 13.9.Osteosys Co. Ltd.
• 13.10.Osteometer Meditech, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer